Myosin VIIA and Rab Interacting Protein (MYRIP) Peptide
MYRIP
Reactivity: Human
Host: Synthetic
BP, Imm
-
- Target See all MYRIP products
- MYRIP (Myosin VIIA and Rab Interacting Protein (MYRIP))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- KDLMEPALES AVMY
- Characteristics
- The peptide was used in the production of ABIN369250 - Goat Anti-MYRIP / SLAC2C Antibody. It is currently untested in blocking applications.
-
-
- Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- MYRIP (Myosin VIIA and Rab Interacting Protein (MYRIP))
- Synonyms
- SLAC2-C Peptide, SLAC2C Peptide, A230081N12Rik Peptide, Slac2-c Peptide, Slac2c Peptide, MYRIP Peptide, si:dkey-189e1.4 Peptide, LOC100156583 Peptide, myosin VIIA and Rab interacting protein Peptide, MYRIP Peptide, Myrip Peptide, myrip Peptide
-
You are here:
